Evidence map›Paper›PMID 37074477›Full record

Trial reportUrolithiasis2023

Use of Moses 2.0 with extended frequency and optimized Moses vs. high-power laser in MiniPCNL: a randomized controlled trial.

Esteban Emiliani, Andres Koey Kanashiro, Josep Balaña, Sofía Fontanet, Julia Aumatell, Julio Calderón-Cortez, Juan Iregui-Parra, Antoni Sanchez-Pui, Francisco Sanchez-Martin, Felix Millan and 1 more

Abstract readRandomized Controlled Trial
PubMed Publisher
In one paragraph

Trial report in Urolithiasis, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Esteban EmilianiDepartment of Urology, Fundación Puigvert. Autonomous University of Barcelona, Calle Cartagena 340, 08025, Barcelona, Spain. emiliani@gmail.com.
Andres Koey KanashiroDepartment of Urology, Fundación Puigvert. Autonomous University of Barcelona, Calle Cartagena 340, 08025, Barcelona, Spain.
Josep BalañaDepartment of Urology, Fundación Puigvert. Autonomous University of Barcelona, Calle Cartagena 340, 08025, Barcelona, Spain.
Sofía FontanetDepartment of Urology, Fundación Puigvert. Autonomous University of Barcelona, Calle Cartagena 340, 08025, Barcelona, Spain.
Julia AumatellDepartment of Urology, Fundación Puigvert. Autonomous University of Barcelona, Calle Cartagena 340, 08025, Barcelona, Spain.
Julio Calderón-CortezDepartment of Urology, Fundación Puigvert. Autonomous University of Barcelona, Calle Cartagena 340, 08025, Barcelona, Spain.
Juan Iregui-ParraDepartment of Urology, Clinica nueva de Cali. Department of Epidemiology, Interdisciplinary Group of Research in Epidemiology and Public Health (GIESP), Libre University, Cali, Colombia.
Antoni Sanchez-PuiDepartment of Urology, Fundación Puigvert. Autonomous University of Barcelona, Calle Cartagena 340, 08025, Barcelona, Spain.
Francisco Sanchez-MartinDepartment of Urology, Fundación Puigvert. Autonomous University of Barcelona, Calle Cartagena 340, 08025, Barcelona, Spain.
Felix MillanDepartment of Urology, Fundación Puigvert. Autonomous University of Barcelona, Calle Cartagena 340, 08025, Barcelona, Spain.
Oriol AngerriDepartment of Urology, Fundación Puigvert. Autonomous University of Barcelona, Calle Cartagena 340, 08025, Barcelona, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of the study was to compare standard high-power laser (with < 80 Hz) to extended frequency (> 100 Hz) lithotripsy during miniPCNL. 40 patients were randomized in to two groups undergoing MiniPCNL. For both groups, the Holmium Pulse laser Moses 2.0 (Lumenis) was used. For group A, standard high-power laser with < 80 Hz, with Moses distance was set using up to 3 J. For Group B, extended frequency (100-120 Hz) was used allowing up to 0.6 J. All patients underwent MiniPCNL using an 18 Fr balloon access. Demographics were comparable between groups. Mean stone diameter was 19 mm (14-23) with no differences between groups (p = 0.14). Mean operative time was 91 and 87 min for group A and B (p = 0.71), mean laser time was similar in both groups, 6.5 min and 7.5 min, respectively (p = 0.52) as well as the number of laser activations during the surgery (p = 0.43). Mean Watts used was 18 and 16 respectively being similar in both groups (p = 0.54) as well as the total KJoules (p = 0.29). Endoscopic vision was good in all surgeries. The endoscopic and radiologic stone free rate was achieved in all patients expect for two in both groups (p = 0.72). Two Clavien I complications were seen, a small bleeding for group A and a small pelvic perforation in group B. The use of high-power holmium laser with extended frequency and optimized Moses was effective and safe being comparable to standard high-power laser for MiniPCNL allowing more versatility with the setting range.

Indexed as

Lasers, Solid-StateLithotripsyLithotripsy, LaserHumansOperative TimeHolmium laserMiniPCNLMosesMoses 2.0

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.